Expression	O
of	O
Bcl	O
-	O
xL	O
,	O
Bax	O
,	O
and	O
p53	O
in	O
primary	B-Cancer
tumors	I-Cancer
and	O
lymph	B-Cancer
node	I-Cancer
metastases	I-Cancer
in	O
oral	B-Cancer
squamous	I-Cancer
cell	I-Cancer
carcinoma	I-Cancer
.	O

Disturbances	O
in	O
expression	O
of	O
apoptosis	O
-	O
associated	O
proteins	O
take	O
part	O
in	O
the	O
development	O
and	O
progression	O
of	O
many	O
human	O
malignancies	B-Cancer
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
the	O
assessment	O
of	O
correlations	O
among	O
proteins	O
involved	O
in	O
apoptosis	O
-	O
Bcl	O
-	O
xL	O
,	O
Bax	O
,	O
and	O
p53	O
-	O
as	O
well	O
as	O
relationships	O
of	O
these	O
proteins	O
with	O
selected	O
clinicopathological	O
features	O
in	O
oral	B-Cancer
squamous	I-Cancer
cell	I-Cancer
carcinoma	I-Cancer
.	O

Consequently	O
,	O
we	O
examined	O
by	O
immunohistochemistry	O
,	O
using	O
the	O
avidin	O
-	O
biotin	O
-	O
peroxidase	O
method	O
,	O
Bcl	O
-	O
xL	O
,	O
Bax	O
,	O
and	O
p53	O
expression	O
in	O
56	O
samples	B-Cancer
of	O
primary	B-Cancer
oral	I-Cancer
squamous	I-Cancer
cell	I-Cancer
carcinoma	I-Cancer
and	O
in	O
22	O
matched	O
pairs	O
of	O
primary	B-Cancer
and	O
metastatic	B-Cancer
tumors	I-Cancer
.	O

The	O
evaluation	O
of	O
immunostaining	O
of	O
Bcl	O
-	O
xL	O
,	O
Bax	O
,	O
and	O
p53	O
was	O
analyzed	O
in	O
10	O
different	O
tumor	B-Cancer
fields	O
,	O
and	O
the	O
mean	O
percentage	O
of	O
tumor	B-Cell
cells	I-Cell
with	O
positive	O
staining	O
was	O
evaluated	O
.	O

The	O
significance	O
of	O
the	O
associations	O
was	O
determined	O
using	O
Spearman	O
correlation	O
analysis	O
and	O
the	O
chi	O
-	O
square	O
test	O
.	O

We	O
found	O
positive	O
Bcl	O
-	O
xL	O
,	O
Bax	O
,	O
and	O
p53	O
immunostaining	O
in	O
44	O
.	O
6	O
%	O
,	O
28	O
.	O
6	O
%	O
,	O
and	O
58	O
.	O
9	O
%	O
of	O
the	O
studied	O
primary	B-Cancer
tumors	I-Cancer
and	O
in	O
63	O
.	O
6	O
%	O
,	O
45	O
.	O
5	O
%	O
,	O
and	O
72	O
.	O
7	O
%	O
of	O
lymph	B-Cancer
node	I-Cancer
metastases	I-Cancer
,	O
respectively	O
.	O

Analysis	O
of	O
associations	O
among	O
studied	O
proteins	O
revealed	O
positive	O
correlation	O
between	O
Bcl	O
-	O
xL	O
and	O
Bax	O
in	O
primary	B-Cancer
tumors	I-Cancer
(	O
P	O
<	O
0	O
.	O
03	O
,	O
r	O
=	O
0	O
.	O
307	O
)	O
.	O

Statistically	O
significant	O
relationship	O
between	O
p53	O
expression	O
in	O
primary	B-Cancer
oral	I-Cancer
cancers	I-Cancer
and	O
its	O
expression	O
in	O
lymph	B-Cancer
node	I-Cancer
metastases	I-Cancer
(	O
P	O
<	O
0	O
.	O
02	O
)	O
as	O
well	O
as	O
increased	O
expression	O
of	O
Bcl	O
-	O
xL	O
,	O
Bax	O
,	O
and	O
p53	O
in	O
metastatic	B-Cancer
sites	I-Cancer
compared	O
with	O
primary	B-Cancer
tumors	I-Cancer
could	O
indicate	O
an	O
association	O
of	O
these	O
proteins	O
with	O
oral	B-Cancer
cancer	I-Cancer
progression	O
and	O
development	O
of	O
metastases	B-Cancer
.	O

Moreover	O
,	O
we	O
suppose	O
that	O
knowledge	O
about	O
heterogeneity	O
between	O
primary	B-Cancer
and	O
metastatic	B-Cancer
tumor	I-Cancer
might	O
help	O
to	O
understand	O
mechanisms	O
of	O
oral	B-Cancer
cancer	I-Cancer
progression	O
.	O

